Archive for January 2022

In a closely watched case nationally, Charles Lieber was convicted last month of making false statements to federal authorities and of making a false income tax return, among other charges. Read More

Vaccinated residents of Massachusetts beginning Monday will be able to access a digital record of their COVID-19 vaccine history. Read More

Akili Interactive made history in 2020 when it won approval from the U.S. Food and Drug Administration for a prescription video game designed to treat attention deficit/hyperactivity disorder (ADHD) in children. Read More

An 18-story tower in Kendall Square built by the Massachusetts Institute of Technology has landed a tenant that made a name for itself as a seafood destination in the Seaport. Read More

Bedford RNA firm Stoke Therapeutics Inc. has signed a collaboration agreement potentially worth nearly $1 billion with San Diego-based Acadia Pharmaceuticals Inc. Read More

A new federal program will launch centers aimed at elevating minority businesses in rural areas. Here’s what business owners need to know. Read More

In a high-stakes presentation at the J.P. Morgan Healthcare conference, Biogen Inc. executives said they wanted to "improve the community’s understanding" of Aduhelm but left less than 10 minutes to answer questions from investors and attendees. Read More

Moderna CEO Stéphane Bancel says the company will have a new Covid-19 vaccine that specifically fights the omicron variant ready for the fall. Read More

With $93 million in new venture capital, Israeli medical device maker MeMed is expanding its commercial efforts in the U.S. after setting up a local headquarters in Andover. Read More

The Cambridge-based gene-editing firm has signed a four-year deal worth up to $1.35 billion with pharmaceutical giant Pfizer Inc. Read More